ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Lyumjev americanpharmaceuticalreview
June 29, 2020The U.S. Food and Drug Administration (FDA) has approved Lyumjev? (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and ...
Pharma Sources Insight July 2025
